Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Meet–Test–Treat for HCV management: patients’ and clinicians’ preferences in hospital and drug addiction services in Italy

Fig. 2

A Relative importance (%) of investigated attributes for the choice of a Meet–Test–Treat pathway for HCV management ((*) Percentages recalculated after excluding the attribute Care setting), and B Preference weight for levels of investigated attributes for the choice of the Meet–Test–Treat pathway, according to hospital and SerD patients

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us